Barroso-Sousa R, Tyekucheva S, Exman P, Umeton R, Hodi FS, Winer EP, et al. TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC). MAST [Internet]. 2019 Sep. 29 [cited 2026 Apr. 17];29(3):5. Available from: https://mastology.org/journal/article/view/728